AI-assisted insulin titration was noninferior to endocrinologists in managing glycemic control among patients with type 2 diabetes.

The median time to treatment initiation is increasing across cancer types, and this appears to be driven by an increase in stage I cancer diagnoses, data suggest.

Odds of being aware lower among non-Hispanic Black individuals, those with no more than some college education.

(HealthDay News) — From 2021 to 2023, the prevalence of current cannabis use increased among older U.S. adults, according to a research letter published online June 2 in JAMA Internal Medicine.

Neurocognitive outcomes do not differ with hypotension-, hypertension-avoidance strategies for patients undergoing noncardiac surgery.

(HealthDay News) — Most individuals in the United States with cannabis use disorder (CUD) do not receive treatment, according to a study published online May 19 in Substance Use & Misuse.

Sibeprenlimab clinically reduces proteinuria in adults with immunoglobulin A nephropathy (IgAN), according to data from a prespecified analysis of the phase 3 VISIONARY trial presented during a ...

The FDA has approved Widaplik (telmisartan, amlodipine and indapamide) for the treatment of hypertension, including as initial treatment, to lower blood pressure.

Infectious complications can result when early stone intervention prevents adequate antibiotic treatment or when surgical delay allows bacterial persistence. It’s important to optimize stone surgery ...

Trial results offer clinically important information on the efficacy and safety of the combination therapy in CKD with type 2 diabetes.

Atacicept, an investigational BAFF (B-cell activating factor)/APRIL (a proliferation-inducing ligand) dual inhibitor, significantly reduced proteinuria in patients with immunoglobulin A nephropathy ...

Adding an ICI to neoadjuvant chemotherapy can improve pCR rates and may improve OS in patients with MIBC, research suggests.